CLINICAL TRIALS BY STATE

Clinical Trials in New Mexico

12+ recruiting studies in New Mexico, updated in real time and displayed in plain English.

BROWSE BY CONDITION IN NEW MEXICO

Bladder CancerBrain Tumor / GliomaBreast CancerCervical CancerColorectal CancerEndometrial / Uterine CancerHead & Neck CancerKidney / Renal Cell CarcinomaLeukemia (AML)Leukemia (CLL)Liver / Hepatocellular CarcinomaLung Cancer (NSCLC)Lung Cancer (SCLC)Lymphoma (Non-Hodgkin)MelanomaMultiple MyelomaOvarian CancerPancreatic Cancer

RECRUITING TRIALS IN NEW MEXICO

RECRUITINGPhase 3

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

NCT06422143 · Little Rock, CARTI Cancer Center ( Site 0006)
RECRUITINGPhase 3

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

NCT06008197 · Birmingham, Birmingham, AL Investigative Site 10012
RECRUITINGPhase 2

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

NCT06672146 · Tucson, Banner University Medical Center - Tucson
RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

NCT06807424 · Glendale, AARA Clinical Research
RECRUITINGPhase 3

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

NCT07166406 · Berkeley, Alta Bates Summit Medical Center-Herrick Campus
RECRUITINGPhase 2

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT05327114 · Centennial, IMMUNOe Health and Research Centers
RECRUITING

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

NCT04871542 · Anchorage, Anchorage Associates in Radiation Medicine
RECRUITINGPhase 3

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

NCT05812807 · Birmingham, University of Alabama at Birmingham Cancer Center
RECRUITINGPhase 2

Psilocybin for Opioid Use Disorder (OUD)

NCT06796062 · Albuquerque, Duke City Recovery Toolbox
RECRUITINGPhase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT07064473 · Anniston, Pinnacle Research Group, LLC
RECRUITINGPhase 3

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

NCT06841354 · Mobile, USA Mitchell Cancer Institute ( Site 0090)
RECRUITINGPhase 3

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

NCT05642611 · Birmingham, University of Alabama at Birmingham Cancer Center

COMMON QUESTIONS

How many clinical trials are available in New Mexico?

There are currently 12+ recruiting clinical trials in New Mexico listed on ClinicalTrials.gov. Clinicals AI makes these easier to browse with plain-language summaries and condition filters.

How do I join a clinical trial in New Mexico?

Browse the listings above, review eligibility criteria, and submit a contact request. A study coordinator will follow up to discuss your eligibility and next steps.

Are clinical trials in New Mexico free?

Most trials cover the investigational treatment and study-related visits at no cost. Some also offer compensation for time and travel. Confirm cost details with each trial coordinator.

What conditions have trials in New Mexico?

New Mexico hosts trials across cancer, cardiovascular disease, diabetes, neurological conditions, mental health, autoimmune disease, and rare conditions. Browse by condition using the links above.

OTHER STATES

CaliforniaNew YorkTexasFloridaPennsylvaniaOhioIllinoisMassachusettsMichiganWashington